Gordon Rustin
- Reproductive Medicine top 0.05%
- Ovarian cancer diagnosis and treatment 117
- Oncology top 0.2%
- PARP inhibition in cancer therapy 31
- Obstetrics and Gynecology top 0.5%
- Endometrial and Cervical Cancer Treatments 23
- Internal Medicine top 1%
-
- Testicular diseases and treatments 56
- Intraperitoneal and Appendiceal Malignancies 31
-
- Gestational Trophoblastic Disease Studies 31
-
- Neuroblastoma Research and Treatments 21
-
- Renal cell carcinoma treatment 16
- Co-authors
- E.S. NewlandsRichard H. J. BeǵentJonathan A. LedermannL. HoldenAnwar R. PadhaniK. D. BagshaweMichael FriedländerCharlie Gourley
- Journals
- Journal of Clinical Oncology (56 papers)British Journal of Cancer (28 papers)Annals of Oncology (16 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Gordon Rustin
245 papers receiving 15.6k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Reproductive Medicine 5.1k
- Oncology 5.3k
- Obstetrics and Gynecology 1.3k
- Radiology, Nuclear Medicine and Imaging 2.5k
- Internal Medicine 402
Countries citing papers authored by Gordon Rustin
This map shows the geographic impact of Gordon Rustin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Rustin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Rustin more than expected).
Fields of papers citing papers by Gordon Rustin
This network shows the impact of papers produced by Gordon Rustin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Rustin. The network helps show where Gordon Rustin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gordon Rustin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 8 | |
| 2 | Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer | 2016 | 1 |
| 3 | 2014 | 14 | |
| 4 | 2014 | 84 | |
| 5 | 2013 | 34 | |
| 6 | 2011 | 164 | |
| 7 | 2011 | 178 | |
| 8 | 2011 | 25 | |
| 9 | 2009 | 64 | |
| 10 | 2007 | 68 | |
| 11 | 2007 | 119 | |
| 12 | 2005 | 21 | |
| 13 | 2002 | 278 | |
| 14 | 1999 | 15 | |
| 15 | Phase I trial of temozolomide using an extended continuous oral schedule. | 1998 | 228 |
| 16 | 1997 | 15 | |
| 17 | 1995 | 88 | |
| 18 | 1991 | 6 | |
| 19 | 1989 | 27 | |
| 20 | 1984 | 107 |
About Gordon Rustin
Gordon Rustin is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 245 papers that have together received 16.0k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (117 papers), Testicular diseases and treatments (56 papers), Gestational Trophoblastic Disease Studies (31 papers), PARP inhibition in cancer therapy (31 papers), Intraperitoneal and Appendiceal Malignancies (31 papers), Endometrial and Cervical Cancer Treatments (23 papers), Neuroblastoma Research and Treatments (21 papers) and Renal cell carcinoma treatment (16 papers). The work is most often cited by research in Reproductive Medicine (5.1k citations), Oncology (5.3k citations) and Obstetrics and Gynecology (1.3k citations). Gordon Rustin has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include E.S. Newlands, Richard H. J. Beǵent, Jonathan A. Ledermann, L. Holden, Anwar R. Padhani, K. D. Bagshawe, Michael Friedländer, Charlie Gourley, Ignace Vergote and Philipp Harter. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Annals of Oncology, European Journal of Cancer and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.